Skip Navigation



BJA Advance Access published online on June 21, 2006
British Journal of Anaesthesia, doi:10.1093/bja/ael152
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
97/2/192    most recent
ael152v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cechova, S.
Right arrow Articles by Zuo, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cechova, S.
Right arrow Articles by Zuo, Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Accepted April 11, 2006

Laboratory Investigation

Inhibition of glutamate transporters increases the minimum alveolar concentration for isoflurane in rats

S. Cechova 1 and Z. Zuo 1 *

1 Department of Anesthesiology, Neuroscience and Neurological Surgery, University of Virginia, Charlottesville, VA 22908, USA

* To whom correspondence should be addressed.
Z. Zuo, E-mail: zz3c{at}virginia.edu


  Abstract

Background. Glutamate transporters [also named excitatory amino acid transporters (EAATs)] bind and take up extracellular glutamate, a major excitatory neurotransmitter, and can regulate glutamatergic neurotransmission in synapses. As anaesthesia is proposed to be induced by enhancing inhibitory neurotransmission, inhibiting excitatory neurotransmission, or both we hypothesize that inhibition of EAAT activity can increase the anaesthetic requirement.

Methods. The minimum alveolar concentration (MAC, the anaesthetic concentration required to suppress movement in response to noxious stimulation in 50% of subjects) for isoflurane was determined in adult male Sprague-Dawley rats after intrathecal administration of EAAT inhibitors.

Results. Application of DL-threo-{beta}-benzyloxyaspartate, a selective EAAT inhibitor, dose- and time-dependently increased the MAC for isoflurane. The MAC was 109 (1)% and 116 (4)% of the baseline, respectively, for 0.2 and 0.4 µmol of DL-threo-{beta}-benzyloxyaspartate 15 min after the injection of the drug (n=5, P<0.05 compared with the baseline MAC). Intrathecal injection of dihydrokainate, a selective inhibitor of EAAT type 2, also increased the MAC for isoflurane.

Conclusions. These results suggest that EAAT in the spinal cord can regulate the requirement of isoflurane to induce immobility. EAAT2 may be involved in this effect.

Keywords: anaesthesia; anaesthetics volatile; complications, immobility; spinal cord.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
M. Smith and R. P. Mahajan
Clinical neuroscience: relevance to current practice
Br. J. Anaesth., July 1, 2007; 99(1): 1 - 3.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Huang, X. Feng, J. J. Sando, and Z. Zuo
Critical Role of Serine 465 in Isoflurane-induced Increase of Cell-surface Redistribution and Activity of Glutamate Transporter Type 3
J. Biol. Chem., December 15, 2006; 281(50): 38133 - 38138.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.